BiX Selected for Shinhan Future's Lab 12th Cohort

BiX has been selected for the 12th cohort of Shinhan Future's Lab, Shinhan Financial Group's flagship startup acceleration program. Representatives of the selected companies gathered for a welcome day at Shinhan Venture Investment's headquarters in Seoul on April 30.

The 12th cohort drew a record 800 applicants, with 46 startups ultimately selected. The program has expanded its support for early-stage companies and young founders while increasing opportunities for startups pursuing global growth.

Selected companies can pursue business collaboration with Shinhan Financial Group affiliates, proof-of-concept projects, dedicated investment opportunities, workspace support, demo-day participation, and connections through Shinhan's international network.

For BiX, the selection creates a new platform for validating and scaling its medical AI technology. The company plans to use the program's collaboration and investment network to advance DeepScout, strengthen clinical and business partnerships, and accelerate its path toward wider deployment.